Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment

Ankyra Therapeutics will provide an update on the status of the ANK-101 Phase 1 ANCHOR clinical…

Continue Reading

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting

Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and…

Continue Reading

KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer

First presentation of data from Phase 3 KRYSTAL-12 study showed statistically significant and clinically meaningful improvement…

Continue Reading

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Akero Therapeutics, Inc. (AKRO)

RADNOR, Pa.–(BUSINESS WIRE)–The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that…

Continue Reading

Government Regulation Creates Blue Oceans

Business innovator Brian Gladden offers new perspective on finding business opportunities. SACRAMENTO, Calif.–(BUSINESS WIRE)–Business executives are…

Continue Reading

Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing

SAN DIEGO–(BUSINESS WIRE)–Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is…

Continue Reading

Leading Independent Proxy Advisory Firm Institutional Shareholder Services Joins Glass Lewis in Recommending Votes “FOR” ALL Nine WisdomTree Board Nominees

ISS Endorses Company’s Leadership and Strong Corporate Governance Practices Firm Emphasizes Company’s Solid Core Business Performance,…

Continue Reading

BAE Systems Honors Humanetics’ HITEC Sensors with a ‘Partner 2 Win’ Supplier of the Year Award

BOSTON–(BUSINESS WIRE)–HITEC Sensors today announced it received the BAE Systems ‘Partner 2 Win’ Supplier of the…

Continue Reading

KalVista Pharmaceuticals Announces New England Journal of Medicine Publishes Oral Sebetralstat Phase 3 Data Demonstrating its Potential to Transform the Treatment Landscape for People with Hereditary Angioedema

– Late-breaking data from phase 3 KONFIDENT trial of sebetralstat published in NEJM and presented concurrently…

Continue Reading

Global Macrocell Baseband Unit Market Analysis and Forecast 2024-2028, with Focus on Non-Massive MIMO, Massive MIMO and Massive Antenna Element (AE) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Macrocell Baseband Unit Market Analysis and Forecast, 2024-2028, 18th Edition” report from EJL…

Continue Reading